Bagmut IY, Movchan OV, Sheremet MI, Lyashenko AO, Dosenko IV, Smolanka Jr. II, Loboda AD, Kolisnyk IL. Hyperglobulinemia as a marker in the development of immune deficiency and complications in inflammatory breast cancer patients with type 2 diabetes mellitus. RJDNMD [Internet]. 25Nov.2022 [cited 15Jun.2026];29(4):389-94. Available from: https://rjdnmd.org/index.php/RJDNMD/article/view/1188